[1]向广生,唐晨思,路博宇,等.凉血散瘀汤结合常规西药治疗IgA肾病疗效及对患者血液流变学、炎性细胞因子水平的影响[J].陕西中医,2024,(1):63-66.[doi:DOI:10.3969/j.issn.1000-7369.2024.01.014]
　XIANG Guangsheng,TANG Chensi,LU Boyu,et al.Effects of Liangxue Sanyu decoction combined with conventional western medicine on hemorheology and inflammatory cytokine levels in patients with IgA nephropathy[J].,2024,(1):63-66.[doi:DOI:10.3969/j.issn.1000-7369.2024.01.014]
点击复制

凉血散瘀汤结合常规西药治疗IgA肾病疗效及对患者血液流变学、炎性细胞因子水平的影响
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2024年1期
页码:
63-66
栏目:
临床研究
出版日期:
2024-01-05

文章信息/Info

Title:
Effects of Liangxue Sanyu decoction combined with conventional western medicine on hemorheology and inflammatory cytokine levels in patients with IgA nephropathy
作者:
向广生1; 唐晨思1; 路博宇1; 张孝利2; 张志强3
(1.石家庄市中医院东院区肾病科,河北 石家庄 050000; 2.华北医疗健康集团石家庄华药医院肾内科,河北 石家庄 050000; 3.河北省赵县中医院内三科,河北 赵县 051530)
Author(s):
XIANG Guangsheng; TANG Chensi; LU Boyu; ZHANG Xiaoli; ZHANG Zhiqiang
(Nephrology Department,Shijiazhuang Traditional Chinese Medicine Hospital Dongyuan District, Shijiazhuang 050000,China)
关键词:
IgA肾病;  凉血散瘀汤;  炎性因子;  血液流变学;  肾功能;  随机对照
Keywords:
IgA nephropathy;  Liangxue Sanyu decoction;  Inflammatory factors;  Hemorheology;  Renal function;  Randomized control
分类号:
R 692.31
DOI:
DOI:10.3969/j.issn.1000-7369.2024.01.014
文献标志码:
A
摘要:
目的:分析凉血散瘀汤结合常规西药治疗IgA肾病对患者血液流变学、炎性细胞因子水平的影响。方法:选入96例IgA肾病患者,随机分为治疗组(48例,常规西药+凉血散瘀汤治疗)、对照组(48例,常规西药治疗),比较总有效率,治疗前后血液流变学指标(全血高切黏度、全血低切黏度)、血清炎性细胞因子[单核细胞趋化因子(MCP-1)、白介素-6(IL-6)]、肾功能指标[血尿酸(BUA)、血肌酐(Scr)]组间比较,统计给药期间患者消化道症状、神经系统症状、四肢及躯干症状等不良反应。结果:治疗总有效率比较,治疗组高于对照组(P<0.05); 治疗后全血高切、低切黏度比较,治疗组低于对照组; 治疗后血清MCP-1、IL-6水平比较,治疗组低于对照组(P<0.05); 治疗后治疗组BUA、Scr水平显著低于对照组(P<0.05); 治疗组四肢及躯干症状、神经系统症状等不良反应总发生率与对照组比较无统计学差异(P>0.05)。结论:给予IgA肾病患者凉血散瘀汤结合常规西药治疗可显著改善其血液流变学,下调炎性细胞因子水平,发挥肾功能保护作用,整体疗效显著且安全性高。
Abstract:
Objective:Analyze the effect of Liangxue Sanyu decoction combined with conventional western medicine in the treatment of IgA nephropathy on the blood rheology and inflammatory cytokine levels of patients.Methods:96 cases of IgA nephropathy were selected and all were treated with conventional western medicine.The treatment group was given Liangxue Sanyu decoction.The total effective rate was compared and the hemorrheological indicators were completed(whole blood high shear viscosity,whole blood low shear viscosity),serum inflammatory cytokines(monocyte chemotactic factor [MCP-1],interleukin-6 [IL-6)]),renal function indicators(blood uric acid [BUA],serum creatinine [Scr])were compared between groups,and adverse reactions such as gastrointestinal symptoms,neurological symptoms,limbs and trunk symptoms of patients during the administration period were counted.Results:The therapeutic effect of the treatment group was better than that of the control group(P<0.05).Comparing the high-shear and low-shear viscosity of whole blood after treatment,the treatment group was lower(P<0.05).Comparison of IL-6,MCP-1,Scr,and BUN levels between groups,the treatment group was lower(P<0.05).Comparing the total incidence of adverse reactions such as trunk symptoms and neurological symptoms,there was no significant difference between groups(P>0.05).Conclusion:Liangxue Sanyu decoction combined with conventional western medicine treatment to patients with IgA nephropathy can significantly improve their hemorrheology,reduce the levels of inflammatory cytokines,and exert a protective effect on renal function.The overall effect is significant and safe.

参考文献/References:

[1] 李平.百令胶囊联合贝那普利治疗IgA肾病的效果观察[J].保健医学研究与实践,2017,14(2):68-69.
[2] 李春梦,屈凯,王春柳,等.血清中IgA/C3检测在IgA肾病诊断中的意义[J].陕西医学杂志,2018,47(1):123-125.
[3] 李智恒,文青,蔡雪妮,等.IgA肾病治疗研究进展[J].新乡医学院学报,2023,40(3):295-300.
[4] 徐丽梨,王伟铭.IgA肾病的治疗进展[J].临床肾脏病杂志,2023,23(1):70-74.
[5] 吴小聪,宣铭杨,郭禹佟,等.IgA肾病的中医“审因论治”策略[J].中国中医药信息杂志,2023,30(6):164-167.
[6] 王睿琪,张晓东,田耘.肾复康Ⅱ号胶囊对IgA肾病大鼠血清醛固酮及肾内小动脉病变的影响[J].陕西中医,2022,43(4):421-426.
[7] 王海燕.肾脏病学[M].2版.北京:人民卫生出版社,1996:716-717.
[8] 中国中西医结合学会肾脏疾病专业委员会.IgA肾病西医诊断和中医辨证分型的实践指南[J].中国中西医结合杂志,2013,33(5):583-585.
[9] 国家食品药品监督管理局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:112-123.
[10] 白雅雯,麻春杰.炎症因子在IgA肾病中的研究进展[J].中国现代医学杂志,2023,33(3):63-68.
[11] 陆娇,杜珍芳,黄敏.黄葵胶囊联合西药治疗IgA肾病临床疗效及对患者尿蛋白与血清炎症因子的影响[J].陕西中医,2020,41(10):1429-1431.
[12] 张逸馨,王耀光.黄文政教授运用疏利少阳三焦法治疗IgA肾病经验管窥[J].天津中医药,2022,39(1):4-7.
[13] 向广生.IgA肾病中西医诊治进展[J].现代中西医结合杂志,2021,30(15):1707-1710.
[14] 邢甜甜,单伟.西红花苷通过抑制氧化应激和炎症反应对糖尿病大鼠肾脏损伤的保护作用[J].陕西医学杂志,2020,49(9):1067-1070.
[15] 郑静,刘旭阳.凉血散瘀汤联合替米沙坦治疗肾虚血瘀型IgA肾病疗效及对肾脏纤维化的影响[J].现代中西医结合杂志,2018,27(32):3546-3549.
[16] 辛家东,张法荣.黑地黄丸治疗慢性肾衰竭药理研究进展[J].吉林中医药,2020,40(7):972-975.
[17] 张璇,姜睿斌,薛松研,等.生地黄及其配伍防治糖尿病肾病微炎症状态的药效机制分析[J].现代中西医结合杂志,2021,30(35):3975-3977,3982.
[18] 李海波,秦大鹏,葛雯,等.青蒿化学成分及药理作用研究进展[J].中草药,2019,50(14):3461-3470.
[19] 李林林,张会敏,宋健,等.青蒿琥酯的抗炎作用及机制研究进展[J].中国实验方剂学杂志,2023,29(12):241-247.
[20] 李智恒,文青,蔡雪妮,等.IgA肾病治疗研究进展[J].新乡医学院学报,2023,40(3):295-300.
[21] 孙丽燕,曹蓉,赵雯红,等.针药联合对IgA肾病伴急性上呼吸道感染患者尿IL-6、血hs-CRP及血液流变学的影响——附40例临床资料[J].江苏中医药,2020,52(12):61-64.
[22] 康靖婉,刘彬.基于网络药理学探讨牡丹皮治疗过敏性紫癜的作用机制[J].中医临床研究,2022(11):15-18.
[23] 伍淳操,郭小红,刘霞,等.近5年牡丹皮现代药学作用研究进展[J].中国新药杂志,2020,29(3):281-284.
[24] 丁晓欢,张天舒,栾佳,等.黄芪颗粒剂联合厄贝沙坦对IgA肾病患者肾功能、炎性因子及免疫功能的影响[J].现代生物医学进展,2020,20(20):3919-3922,3941.
[25] 白雅雯,麻春杰.炎症因子在IgA肾病中的研究进展[J].中国现代医学杂志,2023,33(3):63-68.

相似文献/References:

[1]李二敏.加味当归补血汤对 IgA 肾病患者抑制细胞因子聚集及延缓肾脏纤维化的保护作用*[J].陕西中医,2019,(1):64.
[2]张靖华,梁 冰,吴秋杰,等.固肾宁血合剂治疗IgA肾病疗效及对患者血管内皮生长因子及转移生长因子-β1表达的影响*[J].陕西中医,2019,(6):757.
[3]王睿琪,张晓东,田 耘.肾复康Ⅱ号胶囊对IgA肾病大鼠血清醛固酮及肾内小动脉病变的影响[J].陕西中医,2022,(4):421.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.003]
　WANG Ruiqi,ZHANG Xiaodong,TIAN Yun.Effects of Shenfukang Ⅱ capsule on aldosterone and intrarenal arterioles in IgAN rats[J].,2022,(1):421.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.003]
[4]黄 敏,杜珍芳,张红艳.IgA肾病从风、湿、瘀论治探讨[J].陕西中医,2022,(4):499.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.022]
[5]徐梅秀,李丽琦.《伤寒论》六经辨证在IgA肾病诊治中的指导价值[J].陕西中医,2023,(5):615.[doi:DOI:10.3969/j.issn.1000-7369.2023.05.017]
　XU Meixiu,LI Liqi.The guiding value of six meridians differentiation in diagnosis and treatment of IgA nephropathy in treatise on febrile diseases[J].,2023,(1):615.[doi:DOI:10.3969/j.issn.1000-7369.2023.05.017]
[6]孙 龙,董致郅,王革生,等.凉血散瘀汤对高血压脑出血微创术后患者中医症候积分、神经功能缺损评分的影响[J].陕西中医,2023,(8):1061.[doi:DOI:10.3969/j.issn.1000-7369.2023.08.014]
　SUN Long,DONG Zhizhi,WANG Gesheng,et al.Effect of Liangxue Sanyu decoction on TCM syndrome scores,neurological deficit score of patients with hypertensive intracerebral hemorrhage after minimally invasive surgery[J].,2023,(1):1061.[doi:DOI:10.3969/j.issn.1000-7369.2023.08.014]
[7]毛加荣,刘 稳,芮宏亮,等.IgA肾病107例中医证型与临床、病理及实验室检查相关性分析[J].陕西中医,2023,(9):1231.[doi:DOI:10.3969/j.issn.1000-7369.2023.09.017]
　MAO Jiarong,LIU Wen,RUI Hongliang,et al.Correlation analysis of TCM syndrome types with clinical,pathological and laboratory examination in 107 cases of IgA nephropathy patients[J].,2023,(1):1231.[doi:DOI:10.3969/j.issn.1000-7369.2023.09.017]
[8]艾山江·艾合买提,田 耘.从湿热论治IgA肾病[J].陕西中医,2024,(3):380.[doi:DOI:10.3969/j.issn.1000-7369.2024.03.021]
[9]唐晨思,向广生,张翠娜,等.健脾益肾通络汤对IgA肾病患者肾功能、炎症因子的影响[J].陕西中医,2024,(11):1499.[doi:DOI:10.3969/j.issn.1000-7369.2024.11.012]
　TANG Chensi,XIANG Guangsheng,ZHANG Cuina,et al.Impact of Jianpi Yishen Tongluo decoction on renal function and inflammatory factors in patients with IgA nephropathy[J].,2024,(1):1499.[doi:DOI:10.3969/j.issn.1000-7369.2024.11.012]

备注/Memo

备注/Memo:
基金项目:河北省中医药管理局科研计划项目(2019407)
更新日期/Last Update: 2024-01-09